| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.052 | 0.8 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.019 | 0.8 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.052 | 0.8 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | 0.041 | 0.8 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.014 | 0.8 |